NCT05057013 2025-08-11A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursCancer Research UKPhase 1/2 Active not recruiting81 enrolled
NCT00740532 2010-09-02Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer PatientsIstituto Clinico HumanitasCompleted11 enrolled